Nu Skin Enterprises Q2 Earnings Call Highlights

Impact · against what's priced in

Nu Skin faces significant headwinds as non-cash impairment charges and a delayed India launch weigh on the outlook. While Prysm iO adoption shows sequential growth, it is offset by an admission that recruiting levels are insufficient for sustainable growth.

NUS−0.30

No priced-in read yet

In context

The company reported negative EPS due to $246.4 million in non-cash charges and postponed its India entry to 2027, while acknowledging that recruiting and leadership development remain below sustainable levels.

Read from the article alone

• earnings▲35%
• ai
• NUS
• cost cutting
• direct selling
• goodwill impairment
• india
• margins
• restructuring
• wellness